Cancer Advances Announces Issuance of a New Patent for a Companion…

Cancer Advances, Inc. (Cancer Advances), a wholly owned, biotechnology portfolio company of Cato BioVentures, announces the issuance of a new patent for a companion diagnostic, to be used as a…

(PRWeb July 31, 2012)

Read the full story at http://www.prweb.com/releases/2012/7/prweb9749628.htm


Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!